Gowling WLG advised Eloxx Pharmaceuticals on a licence agreement. Eloxx Pharmaceuticals, a company engaged in the science of ribosome modulation, has recently entered into an exclusive...
Eloxx Pharmaceuticals’ Exclusive Licencing Agreement with Almirall
Sosei Heptares’ Partnership with Boehringer Ingelheim
Gowling WLG advised Sosei Heptares on a multi-million pound drug with Boehringer Ingleheim. Sosei Heptares, a leading biopharmaceutical company, has joined forces with Boehringer Ingelheim in...
Kynos Therapeutics’ £9 Million Financing
Withers tech team has advised biotech research firm Kynos Therapeutics on the deal. Kynos Therapeutics’ £9 million financing consisted of £6.5 million led by Epidarex Capital together with...